Science and Medicine Group Launches a Refreshed Platform for, Moving the Media Property Towards an Increasingly Innovative User Experience



Science and Medicine Group Launches a Refreshed Platform for, Moving the Media Property Towards an Increasingly Innovative User Experience


Arlington, VA November 9th, 2022--  Today, Science and Medicine Group Inc. (SMG), a data intelligence company providing actionable insights to life sciences and healthcare markets, announced platform enhancements to one of their four media properties, These developments are a part of an overarching strategy to enhance digital media experiences across all SMG-owned media properties that elevate content while highlighting sponsors.


As the leading provider of business insights on emerging technology, regulatory and economic trends, is home to an active digital community of clinical laboratory, pathology, and diagnostic industry professionals looking to stay informed on the various factors impacting their industry daily. The site re-platforming includes new features and functionality that will not only benefit readers but give partners a more optimized approach to connecting with those consuming on-site content.


“The editorial team at works tirelessly to keep our readers abreast of emerging trends, breaking news, and business developments affecting the industry. The launch of a new and improved is a natural extension of that work. Our enhanced user experience will ensure readers can easily get to the content they want to read. Additionally, expansions to the technology suite surrounding the site launch, are providing our partners with an opportunity to extend their reach based on cutting-edge techniques,” says Barry Lovette, General Manager, Media at Science and Medicine Group.


Readers and Subscribers of can expect a new navigation, dynamic mobile experience, and modern design and layout. Additionally, new content areas encourage users to take a deep dive into their interests and specialties. For partners, the enhanced technology amplifies their digital marketing efforts with optimized ad delivery and increased social media reach and engagement. New behavioral targeting offers in-depth analysis on how users engage with content, topics, and partner brands and data-driven audience acquisition ensures messaging is reaching the right people. Extending beyond standard metrics, custom reporting is now available giving partners the ability to track campaign performance and modify campaigns accordingly throughout the deployment process.


With the successful launch of the re-platformed, SMG is looking forward, and evaluating how these technology enhancements could be applied to the remainder of their media properties -,, and The Science Advisory Board. Marketing teams are encouraged to reach out to media contact, Keelie Truell, to inquire about 2023 media packages.




About Science and Medicine Group

Science and Medicine Group is on a mission as a premier data intelligence company to deliver actionable insights about hard-to-reach audiences in science and medicine. The company is actively expanding its portfolio of data intelligence solutions, building on the longstanding success of its well-known market research brands, such as Bioinformatics and Kalorama, its media sites, such as,,, and The Science Advisory Board, a network of scientists immersed in biological research, drug discovery and biopharmaceutical production. The company’s breadth of data-driven offerings and value creation across its world-class brands is powering customer product growth and commercialization efforts to create competitive advantages for its customers. The company is based in Arlington, VA. For more information, visit


Media Contact

Keelie Truell

Science and Medicine Group

[email protected]

(703) 935 - 0751